PMID- 19860413 OWN - NLM STAT- MEDLINE DCOM- 20100309 LR - 20211020 IS - 1520-5010 (Electronic) IS - 0893-228X (Print) IS - 0893-228X (Linking) VI - 22 IP - 12 DP - 2009 Dec TI - Structural identification of Diindole agonists of the aryl hydrocarbon receptor derived from degradation of indole-3-pyruvic acid. PG - 1905-12 LID - 10.1021/tx9000418 [doi] AB - Aerobic incubation of the tryptophan transamination/oxidation product indole-3-pyruvic acid (I3P) at pH 7.4 and 37 degrees C yielded products with activity as Ah receptor (AHR) agonists. The extracts were fractionated using HPLC and screened for AHR agonist activity. Two compounds were identified as agonists: 1,3-di(1H-indol-3-yl)propan-2-one (1) and 1-(1H-indol-3-yl)-3-(3H-indol-3-ylidene) propan-2-one (2), with the potency of 2 being 100-fold > 1 [ Nguyen et al. ( 2009 ) Chem. Res. Toxicol. , DOI: 10.1021/tx900043s . ]. Both 1 and 2 showed UV spectra indicative of indole. The molecular formulas were established by high-resolution mass spectrometry (HRMS), and the structures were determined by a combination of NMR methods, including (1)H, natural abundance (13)C, and two-dimensional methods. An intermediate in the oxidation of I3P to 1 is 3-hydroxy-2,4-di(1H-indol-3-yl)butanal (HRMS established the presence of a compound with the formula C(20)H(19)N(2)O(2)). Compound 1 was converted to 2 in air or (faster) with mild oxidants, and 2 could be further oxidized to 1,3-di(3H-indol-3-ylidene)propan-2-one. Determination of the structures allowed estimation of the molar Ah receptor agonist activity of these natural products, similar in potency to known classical AHR inducers. FAU - Chowdhury, Goutam AU - Chowdhury G AD - Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA. FAU - Dostalek, Miroslav AU - Dostalek M FAU - Hsu, Erin L AU - Hsu EL FAU - Nguyen, Linh P AU - Nguyen LP FAU - Stec, Donald F AU - Stec DF FAU - Bradfield, Christopher A AU - Bradfield CA FAU - Guengerich, F Peter AU - Guengerich FP LA - eng GR - P30 ES000267/ES/NIEHS NIH HHS/United States GR - P30 CA014520/CA/NCI NIH HHS/United States GR - R37 CA090426-09/CA/NCI NIH HHS/United States GR - R37 ES005703/ES/NIEHS NIH HHS/United States GR - T32ES007015/ES/NIEHS NIH HHS/United States GR - R37 CA090426/CA/NCI NIH HHS/United States GR - S10 RR019022/RR/NCRR NIH HHS/United States GR - T32 CA009135/CA/NCI NIH HHS/United States GR - S10RR019022/RR/NCRR NIH HHS/United States GR - T32 ES007015/ES/NIEHS NIH HHS/United States GR - P30 ES000267-42/ES/NIEHS NIH HHS/United States GR - R37ES005703/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Chem Res Toxicol JT - Chemical research in toxicology JID - 8807448 RN - 0 (1,3-di(1H-indol-3-yl)propan-2-one) RN - 0 (1-(1H-indol-3-yl)-3-(3H-indol-3-ylidene)propan-2-one) RN - 0 (Indoles) RN - 0 (Receptors, Aryl Hydrocarbon) RN - 4QM0LT13A8 (indol-3-yl pyruvic acid) SB - IM MH - Hydrogen-Ion Concentration MH - Indoles/*chemistry/isolation & purification/metabolism MH - Magnetic Resonance Spectroscopy MH - Mass Spectrometry MH - Receptors, Aryl Hydrocarbon/*agonists/metabolism MH - Spectrophotometry, Ultraviolet MH - Temperature PMC - PMC2801742 MID - NIHMS155733 EDAT- 2009/10/29 06:00 MHDA- 2010/03/10 06:00 PMCR- 2010/12/21 CRDT- 2009/10/29 06:00 PHST- 2009/10/29 06:00 [entrez] PHST- 2009/10/29 06:00 [pubmed] PHST- 2010/03/10 06:00 [medline] PHST- 2010/12/21 00:00 [pmc-release] AID - 10.1021/tx9000418 [doi] PST - ppublish SO - Chem Res Toxicol. 2009 Dec;22(12):1905-12. doi: 10.1021/tx9000418.